GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (NAS:SWAV) » Definitions » Piotroski F-Score

Shockwave Medical (Shockwave Medical) Piotroski F-Score : 5 (As of May. 01, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shockwave Medical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shockwave Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shockwave Medical's Piotroski F-Score or its related term are showing as below:

SWAV' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 7
Current: 5

During the past 7 years, the highest Piotroski F-Score of Shockwave Medical was 7. The lowest was 4. And the median was 5.


Shockwave Medical Piotroski F-Score Historical Data

The historical data trend for Shockwave Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Piotroski F-Score Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial 5.00 4.00 5.00 7.00 5.00

Shockwave Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 7.00 5.00 5.00

Competitive Comparison of Shockwave Medical's Piotroski F-Score

For the Medical Devices subindustry, Shockwave Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shockwave Medical's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shockwave Medical's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 39.125 + 28.862 + 34.986 + 44.305 = $147.3 Mil.
Cash Flow from Operations was 33.962 + 39.737 + 50.651 + 71.703 = $196.1 Mil.
Revenue was 161.066 + 180.165 + 186.02 + 202.979 = $730.2 Mil.
Gross Profit was 140 + 155.672 + 161.507 + 177.663 = $634.8 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(646.089 + 783.247 + 786.604 + 1473.959 + 1566.563) / 5 = $1051.2924 Mil.
Total Assets at the begining of this year (Dec22) was $646.1 Mil.
Long-Term Debt & Capital Lease Obligation was $767.0 Mil.
Total Current Assets was $1,225.3 Mil.
Total Current Liabilities was $104.2 Mil.
Net Income was 14.521 + 25.561 + 35.003 + 140.911 = $216.0 Mil.

Revenue was 93.631 + 120.746 + 131.33 + 144.026 = $489.7 Mil.
Gross Profit was 80.741 + 104.016 + 113.456 + 126.524 = $424.7 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(345.682 + 372.52 + 417.145 + 475.809 + 646.089) / 5 = $451.449 Mil.
Total Assets at the begining of last year (Dec21) was $345.7 Mil.
Long-Term Debt & Capital Lease Obligation was $59.1 Mil.
Total Current Assets was $459.3 Mil.
Total Current Liabilities was $63.4 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shockwave Medical's current Net Income (TTM) was 147.3. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shockwave Medical's current Cash Flow from Operations (TTM) was 196.1. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=147.278/646.089
=0.22795311

ROA (Last Year)=Net Income/Total Assets (Dec21)
=215.996/345.682
=0.62484017

Shockwave Medical's return on assets of this year was 0.22795311. Shockwave Medical's return on assets of last year was 0.62484017. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shockwave Medical's current Net Income (TTM) was 147.3. Shockwave Medical's current Cash Flow from Operations (TTM) was 196.1. ==> 196.1 > 147.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=766.966/1051.2924
=0.72954584

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=59.126/451.449
=0.13096939

Shockwave Medical's gearing of this year was 0.72954584. Shockwave Medical's gearing of last year was 0.13096939. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1225.26/104.205
=11.75816899

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=459.263/63.374
=7.2468678

Shockwave Medical's current ratio of this year was 11.75816899. Shockwave Medical's current ratio of last year was 7.2468678. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shockwave Medical's number of shares in issue this year was 38.272. Shockwave Medical's number of shares in issue last year was 38.087. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=634.842/730.23
=0.86937266

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=424.737/489.733
=0.86728278

Shockwave Medical's gross margin of this year was 0.86937266. Shockwave Medical's gross margin of last year was 0.86728278. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=730.23/646.089
=1.13023128

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=489.733/345.682
=1.41671536

Shockwave Medical's asset turnover of this year was 1.13023128. Shockwave Medical's asset turnover of last year was 1.41671536. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shockwave Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Shockwave Medical  (NAS:SWAV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shockwave Medical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (Shockwave Medical) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.
Executives
Douglas Evan Godshall director, officer: President & CEO SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Frank T Watkins director 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Isaac Zacharias officer: Chief Commercial Officer 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Dan Puckett officer: CFO & Secretary 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Trinh Phung officer: VP, Finance C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Laura Francis director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Sara Toyloy director C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Kevin J. Ballinger director C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Antoine Papiernik director, 10 percent owner 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Sofinnova Capital Vii Fcpr 10 percent owner C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000
Cahill Colin director 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105